Skip to main content

Find Clinical Trials

Home
Conditions
Blood-Borne Infections

Clinical trial condition

Blood-Borne Infections

Explore clinical trials studying Blood-Borne Infections. Study availability and eligibility vary by location and protocol.

8,277 public trials 443 recruiting studies

Refine in advanced search Browse all conditions

Blood-Borne Infections trial results

Completed

HIV and Fat Accumulation

NCT01088295

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: UCLA CARE Center Los Angeles, California, United States

View Trial Details

Completed

Regular HIV Testing Among At-Risk Latino Men

NCT02454725

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: Not specified

View Trial Details

Completed

Long-term Persistence Study in Healthy Adults Previously Vaccinated With Twinrix Adult

NCT01037114

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +12 more
Locations: GSK Investigational Site Ghent, Belgium

View Trial Details

Completed

Prevalence of Hepatitis B in Vallés Occidental. Observational Multicentric Study

NCT02548325

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations: Mútua de Terrassa Terrassa, Barcelona, Spain

View Trial Details

Completed

Racial Difference in HCV/Host Interactions

NCT00071916

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: University of Arkansas Little Rock, Arkansas, United States

University of Tennessee Memphis, Tennessee, United States

Vanderbilt University Nashville, Tennessee, United States

View Trial Details

Completed

Hepatitis B Vaccine for Non-responders

NCT03415672

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations: Vaxinfectio - Antwerp University Antwerp, Belgium

Ziekenhuis Oost-Limburg Genk, Belgium

Maastricht UMC Maastricht, Netherlands

View Trial Details

Completed

Comparative Efficacy of an Intensified Re-vaccination Scheme for Hepatitis B Virus Infection Among Patients Infected With HIV .

NCT02003703

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +9 more
Locations: Hospital Gustavo Fricke Viña del Mar, Valparaiso, Chile

View Trial Details

Completed

Assessing the Impact of an Educational HIV Prevention Intervention in Zambia

NCT03316040

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: Columbia University New York, United States

American Institutes for Research Choma, Zambia

American Institutes for Research Livingstone, Zambia

View Trial Details

Completed

Evaluation of the Safety and Efficacy of Reformulated Raltegravir (MK-0518) 1200 mg Once Daily in Combination With TRUVADA™ in Human Immunodeficiency Virus (HIV)-1 Infected, Treatment-Naive Participants (MK-0518-292)

NCT02131233

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
Locations: Not specified

View Trial Details

Completed

Grazoprevir (MK-5172) and Elbasvir (MK-8742) Combination in Treatment-Naïve Hepatitis C Virus Participants (MK-5172-067)

NCT02251990

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: Not specified

View Trial Details